Quick Answer
Organon & Co. reported Stockholders Equity of $752.00 million for fiscal year 2025.
Organon & Co. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $752.00M | +59.3% |
| 2024 | $472.00M | +774.3% |
| 2023 | -$70.00M | +92.2% |
| 2022 | -$892.00M | +40.8% |
| 2021 | -$1.51B | -127.5% |
| 2020 | $5.49B | -22.0% |
| 2019 | $7.04B | +10.8% |
| 2018 | $6.35B | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $906.00M | +83.8% | +23.6% |
| June 30, 2025 | $733.00M | +409.0% | +35.2% |
| March 31, 2025 | $542.00M | +1029.2% | +14.8% |
| December 31, 2024 | $472.00M | +774.3% | -4.3% |
| September 30, 2024 | $493.00M | +183.7% | +242.4% |
| June 30, 2024 | $144.00M | +125.9% | +200.0% |
| March 31, 2024 | $48.00M | +106.5% | +168.6% |
| December 31, 2023 | -$70.00M | +92.2% | +88.1% |
- Organon & Co. showed an increase of +59.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2018–2025 period, Organon & Co.’s stockholders equity has declined by 88.2% (from $6.35 billion to $752.00 million).
- The most recent figure is from Organon & Co.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: